Delivery Order SPE2DB25D3404-SPE2DB25FUPKP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Phenobarbital 130 mg/mL vials valued at $6,052.44. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Phenobarbital 65 mg/mL vials with a ceiling value of $1,281.64. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and was competitively awarded without any set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,095.09 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials, with an ultimate completion date of July 21, 2025. This non-set-aside contract employs firm fixed pricing and represents a discrete purchase order under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,488 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract is not set aside for any specific business category and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,470.98 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/ml vials. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing federal contract portfolio and will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,095.09 delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/ml vials, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger federal contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phenobarbital 130 mg/ml vials, a medication used for various medical conditions. The contract has a firm fixed price of $5,283.68 and a performance period ending on May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of Phenobarbital 130 mg/ml vials. The contract is a firm-fixed-price delivery order with a ceiling value of $6,273.13 and a period of performance through March 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,089.00 for Phenobarbital 65 mg/mL vials by the Defense Department's Medical Supply Chain. This contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed price contracting and was awarded competitively with no set-aside designation. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,110.01 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This non-competitive delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract employs firm fixed pricing and represents a routine pharmaceutical procurement supporting federal medical supply requirements. This...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPKPDelivery Order
This delivery order, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp on July 23, 2025, covers the supply of Phenobarbital 130 mg/mL vials with a ceiling value of $2,455.30. The contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The award involved no set-aside designation and was competitively awarded through open competition, consistent with AmerisourceBergen's standard federal procurement profile. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor serving military and veteran healthcare systems. The parent IDC with DLA Troop Support Medical enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. This delivery order for Phenobarbital, a controlled barbiturate medication used in neurological treatment protocols, represents a routine fulfillment under the broader pharmaceutical prime vendor agreement established to support federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/23/25 |